| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/09/2001 | CA2398995A1 Lipid hydrolysis therapy for atherosclerosis and related diseases |
| 08/09/2001 | CA2398889A1 Antisense modulation of survivin expression |
| 08/09/2001 | CA2398877A1 Nucleic acids, proteins, and antibodies |
| 08/09/2001 | CA2398678A1 Selective killing of cells by activation of double-stranded rna dependent protein kinase-pkr |
| 08/09/2001 | CA2398255A1 Bcl-2-like polynucleotides, polypeptides, and antibodies |
| 08/09/2001 | CA2396774A1 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 08/08/2001 | EP1122306A1 Novel deoxyribonuclease, gene encoding the same and use thereof |
| 08/08/2001 | EP1121454A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 08/08/2001 | EP1121449A1 Delivery system for porcine somatotropin |
| 08/08/2001 | EP1121448A1 EXPRESSION AND SECRETION OF icIL-1 RECEPTOR ANTAGONIST TYPE II |
| 08/08/2001 | EP1121442A2 Recombinant e1a deleted adenoviral vectors |
| 08/08/2001 | EP1121441A2 Selectively replicating viral vectors |
| 08/08/2001 | EP1121436A2 Non-desensitizing ampa-receptors |
| 08/08/2001 | EP1121435A1 Camel, an alternative translation product of the tumour antigen lage-1 |
| 08/08/2001 | EP1121434A1 A method of modulating cell survival and reagents useful for same |
| 08/08/2001 | EP1121430A1 Human isre-binding protein |
| 08/08/2001 | EP1121429A2 Gene therapy of alzheimer's disease by delivery of an encoded apolipoprotein e |
| 08/08/2001 | EP1121427A1 (mbp1) polypeptides capable of interacting with oncogenic mutants of the p53 protein |
| 08/08/2001 | EP1121426A2 Method for triggering apoptosis in cells |
| 08/08/2001 | EP1121419A1 Tnfr related gene 12 |
| 08/08/2001 | EP1121381A2 Zinc finger binding domains for gnn |
| 08/08/2001 | EP1121374A1 Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods |
| 08/08/2001 | EP1121157A1 A novel component in the hedgehog signalling pathway |
| 08/08/2001 | EP1121150A1 Delta 6 fatty acid desaturase |
| 08/08/2001 | EP1121137A1 Method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 08/08/2001 | EP1121136A2 Methods of administering adenoviral vectors |
| 08/08/2001 | EP1054595A4 Methods and compounds for the genetic treatment of hyperlipidemia |
| 08/08/2001 | EP0960118A4 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon |
| 08/08/2001 | EP0786004B1 Cloning, expression and characterisation of a novel form of phosphatidylinositol-3-kinase |
| 08/08/2001 | CN1307643A Human BMP-7 promoter and method for exploring bone-related substance by using the same |
| 08/08/2001 | CN1307636A Endometriosis-associated gene |
| 08/08/2001 | CN1307487A Method of treating endotoxemia |
| 08/08/2001 | CN1307482A Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
| 08/08/2001 | CN1307125A Polypeptide-human unwinding enzyme C20 and polynucleotide for coding said polypeptide |
| 08/08/2001 | CN1307060A Method for purifying and high-efficiency expression of human hemangio-endothelia inhibin the Pasteur-Pichia yeast and use of said inhibin in treatment of antineoplastic vasopropagation |
| 08/08/2001 | CN1307013A Polypeptide-human zinc finger protein 13 and polynucleotide for coding said polypeptide |
| 08/07/2001 | US6271360 Single-stranded oligodeoxynucleotide mutational vectors |
| 08/07/2001 | US6271359 Genetically engineered vector coding antisense agents; for use in killing preferential target cells or microrganisms |
| 08/07/2001 | US6271354 Microorganism fusion polypeptide; for use in treatment of viral diseases; viricides |
| 08/07/2001 | US6271353 Antibodies specific for human adseverin |
| 08/07/2001 | US6271348 Fusion protein which inhibits transcription in eukaryotic cells; for use as a tool in gene regulation |
| 08/07/2001 | US6271341 Fusion protein associated with the control of gene expression; for use as a tool in controlled gene expression |
| 08/07/2001 | US6271211 Muscle contraction |
| 08/07/2001 | US6271210 Antisense oligonucleotides for mitogen-activated protein kinases as therapy for cancer |
| 08/07/2001 | US6271209 Cationic lipid formulation delivering nucleic acid to peritoneal tumors |
| 08/07/2001 | US6271208 Mixing, particle sizing |
| 08/07/2001 | US6271207 Enhanced expression of transgenes |
| 08/07/2001 | US6271206 Stabilization; drug delivery |
| 08/07/2001 | US6271205 Neurological tumor in mammals |
| 08/07/2001 | US6271200 Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles |
| 08/07/2001 | US6271030 For modulation of c/ebp beta (transcription factor enhancer-binding gene) expression and for treatment of diseases associated with expression of c/ebp beta |
| 08/07/2001 | US6271025 Modified factor VIII cDNA |
| 08/07/2001 | US6271019 Leukemia associated genes |
| 08/07/2001 | US6270996 Enhancing conversion of single stranded adeno-associated virus to double stranded; infecting target cells with the recombinant virus and exposing the infected cells to an agent; gene therapy cancer and cystic fibrosis |
| 08/07/2001 | US6270994 Smad6 and uses thereof |
| 08/07/2001 | US6270992 Histidine kinase of Staphylococcus aureus |
| 08/07/2001 | US6270991 A polynucleotide encoding an amino acid sequence; diagnosis and therapy for streptococcal infections; treatment of otitis media, conjunctivitis, pneumonia, meningitis, and sinusitis |
| 08/07/2001 | US6270989 A homologous recombinant dna construct comprising a targeting sequence, an exogenous regulatory sequence, an exon and an unpaired splice donor site at the 3'end; gene therapy for thrombopoietin, thrombocytopenia, multiple sclerosis |
| 08/07/2001 | US6270969 Recombinational cloning using engineered recombination sites |
| 08/07/2001 | US6270964 Polypeptide used a diagnostic tool in genetic engineering |
| 08/07/2001 | US6270795 Method of making microencapsulated DNA for vaccination and gene therapy |
| 08/07/2001 | US6270762 Relates to polynucleotides and polypeptides of the thymidylate kinase family, as well as their variants. |
| 08/07/2001 | US6270761 Delivery of nucleic acid |
| 08/07/2001 | US6270747 Inhibiting hypersecretion of mucus in lungs and airways by the administration of an egf-r antagonist. |
| 08/02/2001 | WO2001055448A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055447A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055430A1 17 human secreted proteins |
| 08/02/2001 | WO2001055410A2 Ceramidase compositions and methods based thereon |
| 08/02/2001 | WO2001055403A1 A novel polypeptide, a human helix-destabilizing enzyme c20 and the polynucleotide encoding the polypeptide |
| 08/02/2001 | WO2001055393A2 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1 |
| 08/02/2001 | WO2001055391A2 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 08/02/2001 | WO2001055389A1 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 08/02/2001 | WO2001055387A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055385A1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof |
| 08/02/2001 | WO2001055370A2 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES |
| 08/02/2001 | WO2001055368A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055367A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055364A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055362A2 Hybrid adeno-retroviral vector for the transfection of cells |
| 08/02/2001 | WO2001055358A2 Phosphodiesterases |
| 08/02/2001 | WO2001055355A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055350A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055349A1 Modulation of tolerance by altering nfat signalling |
| 08/02/2001 | WO2001055343A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055337A2 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 08/02/2001 | WO2001055336A2 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 08/02/2001 | WO2001055330A2 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses |
| 08/02/2001 | WO2001055328A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055327A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055326A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055325A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055324A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055323A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055322A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055321A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055320A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055319A2 Endocrine related nucleic acids, proteins and antibodies |
| 08/02/2001 | WO2001055318A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055316A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055315A2 Nucleic acids, proteins, and antibodies |